Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

M 1 -selective muscarinic allosteric modulation enhances cognitive flexibility and effective salience in nonhuman primates
Seyed A. Hassani, Adam Neumann, Jason K Russell, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 12

Showing 12 citing articles:

The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Samantha E. Yohn, P.D. Harvey, Stephen K. Brannan, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Acetylcholine modulates prefrontal outcome coding during threat learning under uncertainty
Gaqi Tu, Peiying Wen, Adel Halawa, et al.
eLife (2025) Vol. 13
Open Access
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials
William P. Horan, Colin Sauder, Philip D. Harvey, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 3
Exercise-conditioned plasma ameliorates postoperative cognitive dysfunction by activating hippocampal cholinergic circuit and enhancing BDNF/TrkB signaling
Xiaodi Lu, Wenyong Xiong, Zhuo Chen, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Muscarinic M1 and M4 receptor agonists for schizophrenia: promising candidates for the therapeutic arsenal
Brian Dean
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 12, pp. 1113-1121
Closed Access | Times Cited: 6
IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia.
Brian Dean
Pharmacological Research (2024) Vol. 210, pp. 107510-107510
Open Access | Times Cited: 1
A Multi-task Platform for Profiling Cognitive and Motivational Constructs in Humans and Nonhuman Primates
Marcus R. Watson, Nathan Traczewski, Seema Dunghana, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Emerging psychoactive drugs and the common life events among adolescents in a Nigerian rehabilitation centre
Joshua Falade, Akinwumi Ayodele Akinnuoye, Sunday Sajo, et al.
British Journal of Guidance and Counselling (2024), pp. 1-13
Closed Access
How to Treat Compulsive Facets of Behavioural Addictions
Naomi Fineberg, Luca Pellegrini, Jeremy E. Solly, et al.
Current Addiction Reports (2024)
Closed Access
A Toolbox for Generating Multidimensional 3-D Objects with Fine-Controlled Feature Space: Quaddle 2.0
Xuan Wen, Leo Malchin, Thilo Womelsdorf
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Acetylcholine modulates prefrontal outcome coding during threat learning under uncertainty
Gaqi Tu, Peiying Wen, Adel Halawa, et al.
(2024)
Open Access
Acetylcholine modulates prefrontal outcome coding during threat learning under uncertainty
Gaqi Tu, Peiying Wen, Adel Halawa, et al.
eLife (2024) Vol. 13
Open Access
Page 1

Scroll to top